SSSEK LTD

Company number 14469038 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

SSSEK LTD - Analysis Report

Company Number: 14469038

Analysis Date: 2025-07-20 13:21 UTC

Financial Health Assessment Report for SSSEK LTD


1. Financial Health Score: B-

Explanation:
SSSEK LTD demonstrates a generally stable financial position with positive net assets and shareholders’ funds. However, the declining trend in current assets and net current assets from 2023 to 2024 suggests emerging liquidity concerns. Given it is a micro-entity with limited financial complexity and no audit requirement, the financial health is satisfactory but indicates caution due to shrinking working capital.


2. Key Vital Signs

Metric 2024 Amount (£) 2023 Amount (£) Interpretation
Current Assets 7,707 12,959 Cash and short-term assets have decreased significantly, indicating reduced liquidity.
Current Liabilities 1,139 3,789 Short-term debts have decreased, which is positive but may reflect less operational activity.
Net Current Assets (Working Capital) 6,568 9,170 Positive but declining; working capital is healthy but shrinking, a potential symptom of liquidity tightening.
Net Assets (Equity) 6,568 9,170 Equity remains positive, indicating solvency, but the downward trend suggests capital erosion.
Average Number of Employees 2 2 Stable workforce size, consistent with micro-entity scale.

Interpretation of Vital Signs:

  • The company’s working capital remains positive, which is a "healthy cash flow" sign, but the reduction by almost 28% year-over-year is a symptom of possible operational contraction or increased cash usage.
  • Reduction in both current assets and current liabilities suggests the company might be scaling down operations or experiencing reduced business activity.
  • Positive net assets confirm the company is solvent and able to meet its long-term obligations, a crucial vital sign showing overall financial stamina.

3. Diagnosis

SSSEK LTD is currently in a stable but cautious financial condition. The company maintains positive net assets and working capital, indicating it is financially solvent and capable of meeting short-term liabilities. However, the symptoms of distress lie in the consistent decline in liquidity: the reduced current assets and net current assets suggest the business may be experiencing tighter cash flow or possibly reduced operational scale.

The company is in the micro-entity category, which limits its financial complexity and regulatory burdens but also reflects a small operational scale. The director, Mr. Suhail Kaba, holds full control, which may simplify decision-making but could also concentrate risk.

No signs of overdue filings or administrative issues are noted, which is a positive compliance symptom.


4. Prognosis

If current trends continue without intervention, SSSEK LTD might face increasing liquidity constraints, which could pressure day-to-day operations. However, with positive net assets and a controlled employee base, the company has a solid foundation to manage short-term challenges.

Future financial health will depend on:

  • Improving liquidity by increasing current assets (e.g., cash reserves, receivables management)
  • Controlling or reducing current liabilities further if operational scale decreases
  • Strategic growth initiatives to stabilize or increase turnover and cash inflows.

5. Recommendations

  • Cash Flow Management: Implement stricter monitoring and forecasting of cash inflows and outflows to prevent liquidity shortages. Consider negotiating better payment terms with customers and suppliers.
  • Cost Control: Review operating expenses to identify areas for cost savings without compromising core business functions to improve net asset retention.
  • Growth Initiatives: Explore opportunities to increase revenue streams within the company’s professional and scientific activity sector (SIC 74909). This will help reverse the declining asset trend.
  • Capital Injection: If feasible, consider introducing additional capital or external funding to strengthen the balance sheet and support growth efforts.
  • Regular Financial Reviews: Maintain quarterly financial reviews to detect early symptoms of distress and adjust operations proactively.
  • Stakeholder Communication: Given the sole director’s full control, ensure transparent communication with any investors or lenders about the financial status and recovery plans.

Medical Analogy Summary

SSSEK LTD currently exhibits a stable cardiovascular system (positive net assets and working capital) but with signs of reduced blood flow (declining liquidity). The company is not critically ill but shows symptoms of financial fatigue that require attention to avoid more serious distress. With timely intervention—akin to lifestyle changes and medication—the company can regain financial vitality and ensure long-term wellness.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.